USFDA to review Sanofi isatuximab for treatment of multiple myeloma Medical Dialogues Bureau21 July 2019 9:15 AM ISTSanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
USFDA accepts Allergan license applications to expand Botox label Farhat Nasim11 March 2019 9:30 AM IST"The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...